АОАнна Владимировна Отт

Анна Владимировна Отт

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Анна Владимировна Отт has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Restrictive cardiomyopathy: difficulties in diagnosis and management. A case report

    by N. G. Veselovskaya, A. V. Ott, G. A. Chumakova, E. V. Trubina, Yu. G. Motin, E. S. Frolova, Н. Г Веселовская, А. Н. Отт, Г. А. Чумакова, Е. В. Трубина, et al.

    Intr oduction . Despite recent advances in the diagnosis and treatment of various cardiomyopathies (CMP), the diagnosis of restrictive cardiomyopathy (RCM) remains the most challenging due to the heterogeneity of etiologic factors and the lack of timely interpretation of echocardiographic criteria for myocardial restriction. The association of RCM with the most common cardiovascular diseases further complicates its diagnosis. At the same time, the prognosis for patients with RCM, especially those with a genetic basis, is significantly worse than for other forms of cardiomyopathy. Brief description. This article presents a case of a 47-year-old female patient diagnosed with myocardial infarction complicated by heart failure (HF) refractory to cardiotropic therapy. Delayed assessment of cardiac anatomical parameters (atrial dilation with small ventricular sizes), the type of left ventricular diastolic dysfunction, and the characteristics of myocardial longitudinal strain abnormalities led to a late RCM diagnosis, imitating HF secondary to myocardial infarction. Identification of the genetic disease nature (a mutation in the genes encoding sarcomeric proteins) facilitated the selection of a curative treatment option — heart transplantation. Discussion . This clinical example highlights the need for a thorough approach to diagnosing various cardiomyopathy types using primary and secondary echocardiographic criteria, and, if necessary, genetic testing, especially in cases of refractory heart failure despite ongoing cardiotropic therapy.

  • Open Access

    PREDICTORS OF HOSPITAL COMPLICATIONS FOLLOWING AORTIC VALVE PROSTHESIS IN OBESE PATIENTS

    by Nadezhda G. Veselovskaya, Anna V. Ott, Ekaterina S. Frolova, Vlada E. Sapiyan, Anastasia V. Maslova

    Obesity is a global epidemic of the 21st century. Adipose tissue has pro-inflammatory and pro-fibrotic activity and leads to the development of endothelial dysfunction, resulting in cardiovascular disease (CVD). According to large international studies, obesity is a common comorbid condition in patients with aortic stenosis (AS). Surgical aortic valve replacement (SAVR) remains the «gold» standard for the treatment of patients with severe AS; however, obesity patients represent a group at increased risk of postoperative hospital postoperative complications. Therefore, an important area in modern cardiology is the study of risk factors (RF) for complications after SAVR in patients with obesity, with the development of an individualized preoperative preparation.

  • Open Access

    COVID-19 and post-disease features in patients with obesity

    by Ekaterina S. Frolova, Pavel P. Veselovsky, Galina A. Chumakova, Nadezhda G. Veselovskaya, Anna V. Ott

    The COVID-19 pandemic has affected the global population, causing significant economic effect, material damage, and irreparable human losses. Many countries were forced to promptly reorganize their healthcare system in order to save patients with COVID-19. The pathogenesis and specifics of the disease are not completely understood, but one pattern is particularly clear: COVID-19 tends to be more severe in people with obesity. Fatty tissue is known to support chronic low-grade inflammation and has its own endocrine activity. Over time, it became obvious that some patients still have consequences following the acute phase of COVID-19, which in some cases lead to irreversible changes in the body and reduced quality of life. This condition was called post-COVID syndrome. In this article, we review the long-term effects of COVID-19 on different body systems. We focused on pathogenic infection mechanisms and features of post-COVID syndrome in people with obesity.

  • Open Access

    THE LATE DIAGNOSIS OF DANON DISEASE: THE MORPHOLOGICAL CHARACTERISTICS OF LAMP2-CARDIOMYOPATHY (CASE REPORT)

    by Наталья Владимировна Мотина, Nadezhda G. Veselovskaya, Gennady I. Kostyuchenko, Галина Александровна Чумакова, Анна Владимировна Отт, Yuri G. Motin, Геннадий Иванович Костюченко

    Danons disease is a rare and difficult-to-diagnose X-linked hereditary disease caused by a deficiency of lysosome-associated membrane protein 2 or LAMP2. The main clinical symptoms include myocardial damage with the development of hypertrophic LAMP2 cardiomyopathy, skeletal myopathy, and intellectual impairment. The disease is characterized by a rapidly progressive course, which requires dynamic monitoring of patients. The most significant adverse prognostic factor and the main cause of death is the development of cardiomyopathy. But lysosomal accumulation of glycogen in cardiomyocytes often remains unrecognized as the cause of hypertrophic cardiomyopathy. The aim of the study was to conduct a clinical and morphological analysis of a case of late diagnosis of LAMP2 cardiomyopathy in a 44-year-old female patient. We used data from the medical history, the results of intravital laboratory and instrumental studies, qualitative and quantitative morphological studies of endomyocardial biopsy. The results of the study present clinical signs, the results of a morphological study at the light-optical and electronic microscopic levels, and show the features of the structural rearrangement of cardiomyocytes. The formation of multilamellar myelin-like structures under the sarcolemma of cardiomyocytes was found. There were signs of cell damage - significant uneven vacuolization of the sarcoplasm with the detection of fragments of PAS-positive content in individual vacuoles, distortion of cardiomyocytes. There was a disappearance of transverse striation and local violations of the integrity of the sarcolemma. The interstitium was characterized by loose lymphomononuclear infiltration with an admixture of single segmented leukocytes, edema, and small-focal sclerosis, predominantly of the perimuscular type. In the elements of the microvasculature at the light-optical level, signs of endothelial activation were observed. Based on the combination of clinical and anamnestic data, the results of molecular genetic, morphological studies, a metabolic cause of myocardial hypertrophy, previously not clinically recognized, was established with a morphological picture of LAMP2 cardiomyopathy - Danon disease, and an appropriate diagnosis was made. The authors present a rare case of late detection of Danon disease (LAMP2-cardiomyopathy) with the accumulation of autophagocytic material, glycogen in the sarcoplasm of cardiomyocytes, and the formation of osmiophilic myelin-like structures. The presented clinical case clearly demonstrates the practical significance of ultrastructural pathological examination of endomyocardial biopsy to determine the true form of metabolic hypertrophy and assess the degree of morphological myocardial rearrangement.

  • Morphological features of the myocardium in LAMP2-cardiomyopathy

    by N.V. Motina, N.G. Veselovskaya, G.I. Kostyuchenko, A.V. Ott, V.Ya. Gervald, Yu.G. Motin, Barnaul Altai Regional Cardiology Dispensary, Barnaul Regional Clinical Hospital

    We present a clinical and morphological case study of a delayed LAMP2-cardiomyopathy (Danon disease) in a 44-year-old woman. LAMP2-cardiomyopathy is caused by impaired autophagy processes due to lysosome-associated membrane protein-2 (LAMP-2) deficiency in cardiomyocytes. This is a rare and diagnostically challenging condition inherited in an X-linked dominant pattern. A medical triad includes myocardial damage with hypertrophic LAMP2-cardiomyopathy, intellectual disability, and skeletal myopa-thy, the first one being the most significant prognostic factor and the main cause of death in these patients. However, autophagy disturbance and lysosomal glycogen accumulation in cardiomyocytes often remain unrecognized as the cause of hypertrophic cardiomyopathy. The report briefly describes disease etiology and epidemiology and outlines the clinical findings of the morphological study focusing on intravital ultra-structural features of structural changes in the myocardium. We provide data from the patient’s history, the results of laboratory and imaging studies, as well as endomyocardial biopsy examination at the light-optical and electron microscopic levels. Keywords: Danon disease, hypertrophic cardiomyopathy, LAMP2, electron microscopy